Physician profile
Shea Maloy
NPI 1982124269
$2,477.18
in general payments reported to CMS, 2019-2025
12 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $301 · 2023: $618 · 2024: $917 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,064 · Travel and Lodging: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.15 |
| Travel and Lodging | $112.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $501.52 | 2023-2024 | |
| Rti Surgical, INC | $449.47 | 2024-2025 | |
| Integra Lifesciences Corporation | $306.29 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $284.16 | 2022-2025 | Restrata Wound Matrix |
| Kerecis Limited | $195.98 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Merz North America, INC. | $149.42 | 2025 | |
| Motiva USA, LLC | $138.05 | 2025 | |
| Kci USA, INC. | $129.60 | 2022-2023 | V.A.C. Veraflo |
| Polynovo North America LLC | $119.77 | 2024 | Novosorb Btm |
| Baxter Healthcare | $104.00 | 2022 | |
| Solventum Corporation | $81.83 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Elite Orthopedics, LLC | $17.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shea Maloy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.